The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Recovery of humoral immunity in patients with durable complete responses following chimeric antigen receptor modified t cells directed against CD19 (CTL019).
 
Stephen J. Schuster
Consulting or Advisory Role - Celgene; Genentech/Roche; Gilead Sciences; Nordic Nanovector; Novartis; Pharmacyclics
Research Funding - Celgene; Genentech/Roche; Novartis
 
Jakub Svoboda
Consulting or Advisory Role - Seagen
Research Funding - Celgene; MedImmune; Pharmacyclics; Seagen
 
Sunita Nasta
Research Funding - Millennium
 
Elise A. Chong
No Relationships to Disclose
 
David L. Porter
Employment - Genentech/Roche (I)
Stock and Other Ownership Interests - Genentech/Roche (I)
Honoraria - Incyte
Consulting or Advisory Role - Novartis
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Patent/royalty rights
Travel, Accommodations, Expenses - Immunovative Therapies
 
Daniel Jeffrey Landsburg
No Relationships to Disclose
 
Anthony R. Mato
Consulting or Advisory Role - Abbvie; Gilead Sciences; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie; Acerta Pharma; Gilead Sciences; ProNAi; TG Therapeutics
 
Vijay G. Bhoj
Research Funding - Novartis; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor on Chimeric Antigen Receptor patents which are pending
 
Michael Milone
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from granted and pending patents licensed to Novartis
 
Simon F. Lacey
Research Funding - Novartis
 
Lauren E. Strelec
Research Funding - Celgene (Inst); MedImmune (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - MedImmune
 
Alice Y. Zhou
No Relationships to Disclose
 
Jan J. Melenhorst
Research Funding - Novartis (Inst)
 
Anne Chew
Research Funding - Novartis (Inst)
 
Jens Hasskarl
Employment - Novartis
 
Mariusz A. Wasik
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Seagen
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - NPM-ALK as an omncogene
 
Katherine Marcucci
Research Funding - Novartis (Inst)
 
Zhaohui Zheng
Patents, Royalties, Other Intellectual Property - Novartis
 
Bruce Levine
Stock and Other Ownership Interests - Tmunity Therapeutics, Inc.
Honoraria - Novartis
Consulting or Advisory Role - TERUMO
Research Funding - Novartis; Takara Bio
Patents, Royalties, Other Intellectual Property - intellectual property and patents in the field of cell and gene therapy
Travel, Accommodations, Expenses - TERUMO
 
Carl H. June
Stock and Other Ownership Interests - Celldex; Immune Design; Tmunity Therapeutics, Inc.
Honoraria - Johnson & Johnson; Novartis; Pfizer
Consulting or Advisory Role - Celldex; Immune Design
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; IP licensed to Tmunity (Inst); Office of Naval Research; IP and patent royalties